CRM
62
3
WAT
41
3
LRCX
74
3
FRT
55
-3
AIZ
56
-3
EMN
62
2
SHW
59
3
FE
41
3
NRG
62
3
RCL
66
-3
ESS
59
-3
SYF
79
-2
FDX
58
-2
ORLY
49
-3
AA
51
7
VFC
36
2
EQIX
52
-2
CFG
54
-2
STZ
60
-4
SEE
36
3
CRM
62
3
WAT
41
3
LRCX
74
3
FRT
55
-3
AIZ
56
-3
EMN
62
2
SHW
59
3
FE
41
3
NRG
62
3
RCL
66
-3
ESS
59
-3
SYF
79
-2
FDX
58
-2
ORLY
49
-3
AA
51
7
VFC
36
2
EQIX
52
-2
CFG
54
-2
STZ
60
-4
SEE
36
3
Financhill
Back

Cytokinetics Stock Price Chart

20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Sign up now to get this report and avoid a high-yield dividend trap - Yours FREE.
Buy
57

CYTK
Cytokinetics

Last Price:
54.43
Seasonality Move:
8.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Nvidia's march to $5 trillion

Click here to see how Nvidia's march to $5 trillion could impact its partners.
  • The current trend is relatively stagnant and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

Cytokinetics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 53.81 Buy
20-day SMA: 53.42 Buy
50-day SMA: 56.72 Sell
200-day SMA: 56.39 Sell
8-day EMA: 53.97 Buy
20-day EMA: 53.78 Buy
50-day EMA: 56.77 Sell
200-day EMA: 56.69 Sell

Cytokinetics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.47 Sell
Relative Strength Index (14 RSI): 50.4 Buy
Chaikin Money Flow: -331017 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.4 - 54.56) Buy
Bollinger Bands (100): (54.96 - 72.78) Sell

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cytokinetics Stock

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 54.40 while CYTK 8-day simple moving average is 53.81, which is a Buy signal.
  • The stock price of CYTK is 54.40 while Cytokinetics 20-day SMA is 53.42, which makes it a Buy.
  • Cytokinetics 50-day simple moving average is 56.72 while CYTK share price is 54.40, making it a Sell technically.
  • CYTK stock price is 54.40 and Cytokinetics 200-day simple moving average is 56.39, creating a Sell signal.

CYTK Technical Analysis vs Fundamental Analysis

Buy
57
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy or a Sell?

  • Cytokinetics stock is rated a Buy
    The current Cytokinetics [CYTK] share price is $54.40. The Score for CYTK is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.

Cytokinetics Stock Info

Market Cap:
5.7B
Price in USD:
54.40
Share Volume:
487.23K

Cytokinetics 52-Week Range

52-Week High:
110.25
52-Week Low:
25.98
Buy
57
Cytokinetics (CYTK) is a Buy

Cytokinetics Share Price Forecast

  • What is the Cytokinetics stock price today?
    The Cytokinetics stock price is 54.40 USD today.
  • Will CYTK stock go up or go down?
    Cytokinetics> share price is forecast to RISE/FALL based on technical indicators
  • Is Cytokinetics overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytokinetics is not overvalued.

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 54.40 while CYTK 8-day exponential moving average is 53.97, which is a Buy signal.
  • The stock price of CYTK is 54.40 while Cytokinetics 20-day EMA is 53.78, which makes it a Buy.
  • Cytokinetics 50-day exponential moving average is 56.77 while CYTK share price is 54.40, making it a Sell technically.
  • CYTK stock price is 54.40 and Cytokinetics 200-day simple moving average is 56.69, creating a Sell signal.

Fundamental Analysis of Cytokinetics

Is Cytokinetics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.56 per share, and an increase next year of $0.15 per share.

Technical Analysis of Cytokinetics

Should I short Cytokinetics stock?

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.